SPIRO-QUINAZOLINONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS

The present invention relates to novel spiro-quinazolinone derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling.

Saved in:
Bibliographic Details
Main Authors HAXELL THOMAS FRANCIS NELSON, SUTTON AMANDA E, DORSEY JAMES M, FOGLESONG ROBERT JAMES, BRUGGER NADIA, RICHARDSON THOMAS E, HODOUS BRIAN L, POTNICK JUSTIN, JOHNSON THERESA L
Format Patent
LanguageEnglish
Published 30.09.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel spiro-quinazolinone derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling.
Bibliography:Application Number: CN201480007416